-transparent.png){kind=logo}
On the basis of our own studies and those of others, we suggest that several DQ molecules may be involved in IDDM susceptibility (Table 2). Our studies suggest that these DQ molecules may be encoded both when the DQA1 and DQB1 genes are in cis or trans position. A common denominator of several of these IDDM susceptibility molecules is that they have a non-Asp amino acid at DQ beta chain residue 57. Our studies demonstrate that this residue may be an important residue for peptide presentation to T cells.
Related Publications
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
August 1992,
Scandinavian journal of immunology,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
June 1990,
The New England journal of medicine,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
May 1993,
Diabetologia,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
December 1998,
Human immunology,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
July 1994,
Zhonghua yi xue za zhi,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
January 1987,
Nature,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
April 1990,
The Journal of clinical investigation,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
January 1999,
Journal of pediatric endocrinology & metabolism : JPEM,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
January 1990,
Current topics in microbiology and immunology,
E Thorsby, and
H A Gjertsen, and
K E Lundin, and
K S Rønningen
May 2002,
American journal of medical genetics,
